Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

IDX/MARK stock hub

IDX/MARK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/MARKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2T

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/MARK

In the news

Latest news · IDX/MARK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/E10.7

P25 11.5P50 23.8P75 52.6

ROE31

P25 0.6P50 5.1P75 12.2

ROIC33.3

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/MARK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

IDR

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	656
Employees Change	112%
Employees Change Percent	20.59
Enterprise value	IDR 3.1T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	ID1000140106
Last refreshed	2026-05-10
Market cap	IDR 3.2T
Price	IDR 840
Price currency	IDR
Rev Per Employee	1,349,264,256.38x
Sector	Healthcare
Sic	3590
Symbol	idx/MARK
Website	https://www.markdynamicsindo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.31%
EV Earnings	10.29x
EV/EBIT	8.34x
EV/EBITDA	8.16x
EV/FCF	11.08x
EV/Sales	3.46x
FCF yield	8.64%
P/B ratio	3.24x
P/E ratio	10.74x
P/S ratio	3.61x
PE Ratio10 Y	16.59x
PE Ratio3 Y	13.69x
PE Ratio5 Y	12.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	41.42%
EBITDA Margin	42.35%
FCF margin	31.17%
Gross margin	48.96%
Gross Profit	IDR 433.4B
Gross Profit Growth	0.26%
Gross Profit Growth Q	11.32%
Gross Profit Growth3 Y	19.24%
Gross Profit Growth5 Y	7.21%
Net Income	IDR 297.3B
Net Income Growth	4.57%
Net Income Growth Q	19.16%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	26.04%
Net Income Growth5 Y	9.37%
Pretax Margin	42.86%
Profit Margin	33.59%
Profit Per Employee	IDR 453.2M
Profitable Years	12
ROA	21.84
Roa5y	22.55
ROCE	36.76
ROE	31.03
Roe5y	36.61
ROIC	33.28
Roic5y	34.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	15.79%
Cagr3y	19.23%
Cagr5y	4.11%
Div CAGR3	11.87%
Div CAGR5	58.49%
EPS Growth	4.57
EPS Growth Q	19.16
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	26.04
EPS Growth5 Y	9.37
FCF Growth	-12.73%
FCF Growth Q	80.15%
FCF Growth3 Y	6.78%
FCF Growth5 Y	37.28%
OCF Growth	-9.34%
OCF Growth Q	77.59%
OCF Growth3 Y	4.55%
OCF Growth5 Y	5%
Revenue Growth	-1.77x
Revenue Growth Q	23.55x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	14.32x
Revenue Growth5 Y	5.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.84
Assets	IDR 1.1T
Cash	IDR 142.8B
Current Assets	IDR 552.2B
Current Liabilities	IDR 82B
Debt	IDR 6.2B
Debt EBITDA	IDR 0.02
Debt Equity	IDR 0.01
Debt FCF	IDR 0.02
Equity	IDR 985.2B
Interest Coverage	275.1
Liabilities	IDR 93.9B
Long Term Assets	IDR 526.9B
Long Term Liabilities	IDR 11.9B
Net Cash	IDR 136.6B
Net Cash By Market Cap	IDR 4.28
Net Cash Growth	6.71%
Net Debt EBITDA	IDR -0.36
Net Debt Equity	IDR -0.14
Net Debt FCF	IDR -0.5
Tangible Book Value	IDR 982.3B
Tangible Book Value Per Share	IDR 259
WACC	5.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.73
Inventory Turnover	2.77
Net Working Capital	IDR 333.6B
Quick ratio	4.32
Working Capital	IDR 470.2B
Working Capital Turnover	IDR 1.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	IDR 70
Dividend Years	8
Dividend Yield	8.33%
Last Dividend	IDR 20
Payout Ratio	89.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	15.77%
200-day SMA	738.9
3Y total return	69.52%
50-day SMA	796.2
50-day SMA vs 200-day SMA	50over200
5Y total return	22.29%
All Time High	1,380
All Time High Change	-39.13%
All Time High Date	2022-01-21
All Time Low	74.8
All Time Low Change	1,022.99%
All Time Low Date	2017-07-12
ATR	26.11
Beta	0.31
Beta1y	0.35
Beta2y	0.37
Ch YTD	1.82
High	855
High52	905
High52 Date	2025-12-01
High52ch	-7.18%
Low	815
Low52	585
Low52 Date	2025-09-01
Low52ch	43.59%
Ma50ch	5.5%
Price vs 200-day SMA	13.69%
RSI	60.29
RSI Monthly	52.72
RSI Weekly	57.58
Sharpe ratio	0.11x
Sortino ratio	0.34
Total Return	8.33%
Tr YTD	1.82
Tr1m	5%
Tr1w	5.66%
Tr3m	1.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 366.6B
Operating Income Growth	4.31
Operating Income Growth Q	19.68
Operating Income Growth3 Y	23.43
Operating Income Growth5 Y	8.29
Operating margin	41.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	749,797,857%
Net Borrowing	-13,912,670,089
Shares Insiders	1.79%
Shares Institutions	0.01%
Shares Out	3,800,000,310
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR 275.9B
Average Volume	9,305,445x
Bv Per Share	258.5
CAPEX	IDR -23.2B
Ch1m	5
Ch1w	5.66
Ch1y	5
Ch3m	1.21
Ch3y	33.33
Ch5y	-9.68
Ch6m	24.44
Change	2.44%
Change From Open	2.44
Close	820
Days Gap	0
Depreciation Amortization	8,268,710,611
Dollar Volume	20,613,096,000
Earnings Date	2026-05-12
EBIT	IDR 366.6B
EBITDA	IDR 374.8B
EPS	IDR 78.24
F Score	5
FCF	IDR 275.9B
FCF EV Yield	9.02x
FCF Per Share	IDR 72.61
Financing CF	-281,245,192,315
Fiscal Year End	December
Founded	2,002
Graham Number	674.5772
Graham Upside	-19.69
Income Tax	IDR 82B
Investing CF	-19,946,995,970
Is Primary Listing	1
Last Earnings Date	2025-10-27
Last Report Date	2026-03-31
Last Split Date	2019-02-11
Last Split Type	Forward
Lynch Fair Value	IDR 733
Lynch Upside	-12.74
Ma150	767.5
Ma150ch	9.44%
Ma20	813.3
Ma20ch	3.29%
Net CF	-2,117,234,786
Next Earnings Date	2026-05-12
Open	820
P FCF Ratio	11.57
P OCF Ratio	10.67
Payment Date	2025-11-27
Position In Range	62.5
Ppne	502,213,237,838
Price Date	2026-05-08
Price EBITDA	IDR 8.52
Ptbv Ratio	3.25
Relative Volume	2.79x
Revenue	885,117,352,186x
Tax By Revenue	9.27x
Tax Rate	21.62%
Tr6m	24.44%
Volume	24,539,400
Z Score	21.47

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IDX/MARK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+8.3%

$70.0 annual per share

Payout ratio

+89.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+58.5%

0 consecutive years of growth

Total shareholder yield

+8.3%

Dividend yield + buyback yield combined

Performance

IDX/MARK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/MARK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IDX/MARK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.3

Neutral momentum band

Price vs 200-day MA

+13.7%

50/200-day relationship not available

Beta (5Y)

0.31

Less volatile than the market

Sharpe ratio

0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/MARK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/MARK stock rating?

idx/MARK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/MARK analysis?

The full report lives at /stocks/idx/MARK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/MARK?

The latest report frames idx/MARK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/MARK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.